Abstract
Members of the transforming growth factor β (TGF-β) family regulate cell proliferation, migration, and differentiation during embryonal development and in tissue homeostasis in the adult. They signal by inducing heteromeric complexes of type I and type II serine/threonine kinase receptors. Ligand binding activates the type I receptor kinase leading to phosphorylation of members of the Smad family, which after oligomerization are translocated to the nucleus where they together with other nuclear factors regulate the transcription of specific genes. TGF-β family members also signal via non-Smad pathways, including Erk, JNK, and p38 MAP-kinase pathways, the tyrosine kinase Src, the small GTPase Rho, and cleavage of the type I receptor whereby the intracellular domain is translocated to the nucleus where it drives an invasiveness program. The TGF-β signaling pathways are carefully regulated by posttranslational mechanisms, including phosphorylation, ubiquitination, acetylation, sumoylation, and PAR-ylation, as well as by positive and negative feedback mechanisms and cross talk with other signaling pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agricola E, Randall RA, Gaarenstroom T et al (2011) Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell 43:85–96
Ahn SM, Cha JY, Kim J et al (2012) Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene 31:3051–3059
Akiyoshi S, Inoue H, Hanai J et al (1999) c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J Biol Chem 274:35269–35277
Alarcón C, Zaromytidou AI, Xi Q et al (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139:757–769
Ameln AK, Muschter A, Mamlouk S et al (2011) Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ. Cancer Res 71:3306–3316
Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFβ activation. J Cell Sci 116:217–224
Aoyagi-Ikeda K, Maeno T, Matsui H et al (2011) Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-β-Smad3 pathway. Am J Respir Cell Mol Biol 45:136–144
Aragon E, Goerner N, Zaromytidou AI et al (2011) A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev 25:1275–1288
Bandyopadhyay B, Han A, Dai J et al (2011) TβRI/Alk5-independent TβRII signaling to ERK1/2 in human skin cells according to distinct levels of TβRII expression. J Cell Sci 124:19–24
Batut J, Howell M, Hill CS (2007) Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-β ligands. Dev Cell 12:261–274
Batut J, Schmierer B, Cao J et al (2008) Two highly related regulatory subunits of PP2A exert opposite effects on TGF-β/Activin/Nodal signalling. Development 135:2927–2937
Bengoechea-Alonso MT, Ericsson J (2010) Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation. Oncogene 29:5322–5328
Benus GF, Wierenga AT, de Gorter DJ et al (2005) Inhibition of the transforming growth factor β (TGFβ) pathway by interleukin-1β is mediated through TGFβ-activated kinase 1 phosphorylation of SMAD3. Mol Biol Cell 16:3501–3510
Bizet AA, Tran-Khanh N, Saksena A et al (2012) CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. J Cell Biochem 113:238–246
Buscemi L, Ramonet D, Klingberg F et al (2011) The single-molecule mechanics of the latent TGF-β1 complex. Curr Biol 21:2046–2054
Chandra M, Zang S, Li H et al (2012) Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing. Mol Cell Biol 32:2183–2195
Chang CC, Lin DY, Fang HI et al (2005) Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4. J Biol Chem 280:10164–10173
Chaudhury A, Hussey GS, Ray PS et al (2010) TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12:286–293
Clarke DC, Brown ML, Erickson RA et al (2009) Transforming growth factor β depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol 29:2443–2455
Dai F, Lin X, Chang C, Feng XH (2009) Nuclear export of Smad2 and Smad3 by RanBP3 facilitates termination of TGF-β signaling. Dev Cell 16:345–357
Daly AC, Vizan P, Hill CS (2010) Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-β responses. J Biol Chem 285:6489–6497
Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56–61
Davis BN, Hilyard AC, Nguyen PH et al (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39:373–384
Davis-Dusenbery BN, Chan MC, Reno KE et al (2011) Down-regulation of Krüppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-β and bone morphogenetic protein 4. J Biol Chem 286:28097–28110
de Caestecker MP, Parks WT, Frank CJ et al (1998) Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12:1587–1592
de Graauw M, van Miltenburg MH, Schmidt MK et al (2010) Annexin A1 regulates TGF-β signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA 107:6340–6345
Dennler S, Itoh S, Vivien D et al (1998) Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091–3100
Derynck R, Miyazono K (eds) (2007) The TGF-β family. Cold Spring Harbor Laboratory Press, New York
Descargues P, Sil AK, Sano Y et al (2008) IKKα is a critical coregulator of a Smad4 independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci USA 105:2487–2492
Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL (2003) Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 5:410–421
Dong C, Li Z, Alvarez R Jr et al (2000) Microtubule binding to Smads may regulate TGFβ activity. Mol Cell 5:27–34
Duan X, Liang YY, Feng XH, Lin X (2006) Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 281:36526–36532
Dupont S, Zacchigna L, Cordenonsi M et al (2005) Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121:87–99
Dupont S, Mamidi A, Cordenonsi M et al (2009) FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell 136:123–135
Ebisawa T, Fukuchi M, Murakami G et al (2001) Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276:12477–12480
Edlund S, Landström M, Heldin C-H, Aspenström P (2002) Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13:902–914
Edlund S, Bu S, Schuster N et al (2003) Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14:529–544
Edlund S, Landström M, Heldin C-H, Aspenström P (2004) Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42. J Cell Sci 117:1835–1847
Edlund S, Lee SY, Grimsby S et al (2005) Interaction between Smad7 and β-catenin: importance for transforming growth factor β-induced apoptosis. Mol Cell Biol 25:1475–1488
Eichhorn PJ, Rodon L, Gonzalez-Junca A et al (2012) USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med 18:429–435
Ferrand N, Atfi A, Prunier C (2010) The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-β type I receptor. Cancer Res 70:8457–8466
Fischer AN, Fuchs E, Mikula M et al (2007) PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progression. Oncogene 26:3395–3405
Fukuchi M, Imamura T, Chiba T et al (2001) Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell 12:1431–1443
Gal A, Sjöblom T, Fedorova L et al (2008) Sustained TGF-β exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27:1218–1230
Gao S, Alarcon C, Sapkota G et al (2009) Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell 36:457–468
Gomis RR, Alarcon C, He W et al (2006) A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci USA 103:12747–12752
Gotzmann J, Fischer AN, Zojer M et al (2006) A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes. Oncogene 25:3170–3185
Goumans M-J, Valdimarsdottir G, Itoh S et al (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol Cell 12:817–828
Grönroos E, Hellman U, Heldin C-H, Ericsson J (2002) Control of Smad7 stability by competition between acetylation and ubiquitination. Mol Cell 10:483–493
Gu AD, Wang Y, Lin L et al (2012) Requirements of transcription factor Smad-dependent and independent TGF-β signaling to control discrete T-cell functions. Proc Natl Acad Sci USA 109:905–910
Guo X, Ramirez A, Waddell DS et al (2008) Axin and GSK3-control Smad3 protein stability and modulate TGF-β signaling. Genes Dev 22:106–120
Häger M, Pedersen CC, Larsen MT et al (2011) MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors. Blood 118:6649–6659
Halder SK, Rachakonda G, Deane NG, Datta PK (2008) Smad7 induces hepatic metastasis in colorectal cancer. Br J Cancer 99:957–965
Hannigan A, Smith P, Kalna G et al (2010) Epigenetic downregulation of human disabled homolog 2 switches TGFβ from a tumor suppressor to a tumor promoter. J Clin Invest 120:2842–2857
Hayashi H, Abdollah S, Qiu Y et al (1997) The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165–1173
Hayes S, Chawla A, Corvera S (2002) TGF β receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 158:1239–1249
He W, Dorn DC, Erdjument-Bromage H et al (2006) Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway. Cell 125:929–941
Heikkinen PT, Nummela M, Jokilehto T et al (2010a) Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. Cancer Res 70:5984–5993
Heikkinen PT, Nummela M, Leivonen SK et al (2010b) Hypoxia-activated Smad3-specific dephosphorylation by PP2A. J Biol Chem 285:3740–3749
Heldin C-H, Vanlandewijck M, Moustakas A (2012) Regulation of EMT by TGFβ in cancer. FEBS Lett 586:1959–1970
Hesling C, Fattet L, Teyre G et al (2011) Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells. EMBO Rep 12:665–672
Ho J, Cocolakis E, Dumas VM et al (2005) The G protein-coupled receptor kinase-2 is a TGF-β-inducible antagonist of TGFβ signal transduction. EMBO J 24:3247–3258
Hofmann TG, Stollberg N, Schmitz ML, Will H (2003) HIPK2 regulates transforming growth factor-β-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63:8271–8277
Holm TM, Habashi JP, Doyle JJ et al (2011) Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358–361
Horiguchi K, Sakamoto K, Koinuma D et al (2012) TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene 31:3190–3201
Hu D, Wan Y (2011) Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-β signaling. J Biol Chem 286:6890–6901
Hu H, Milstein M, Bliss JM et al (2008) Integration of transforming growth factor β and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration. Mol Cell Biol 28:1573–1583
Hua F, Mu R, Liu J et al (2011) TRB3 interacts with SMAD3 promoting tumor cell migration and invasion. J Cell Sci 124:3235–3246
Huang T, David L, Mendoza V et al (2011) TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs. EMBO J 30:1263–1276
Hyytiäinen M, Penttinen C, Keski-Oja J (2004) Latent TGF-β binding proteins: extracellular matrix association and roles in TGF-β activation. Crit Rev Clin Lab Sci 41:233–264
Ikushima H, Komuro A, Isogaya K et al (2008) An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling. EMBO J 27:2955–2965
Imoto S, Ohbayashi N, Ikeda O et al (2008) Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-β signaling. Biochem Biophys Res Commun 370:359–365
Inman GJ, Nicolas FJ, Hill CS (2002) Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 10:283–294
Inui M, Manfrin A, Mamidi A et al (2011) USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol 13:1368–1375
Itoh S, Landström M, Hermansson A et al (1998) Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J Biol Chem 273:29195–29201
Kamaraju AK, Roberts AB (2005) Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-β-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 280:1024–1036
Kamiya Y, Miyazono K, Miyazawa K (2010) Smad7 inhibits transforming growth factor-β family type I receptors through two distinct modes of interaction. J Biol Chem 285:30804–30813
Kaneko S, Chen X, Lu P et al (2011) Smad inhibition by the Ste20 kinase Misshapen. Proc Natl Acad Sci USA 108:11127–11132
Kang JS, Saunier EF, Akhurst RJ, Derynck R (2008) The type I TGF-β receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 10:654–664
Kavsak P, Rasmussen RK, Causing CG et al (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell 6:1365–1375
Kim KK, Wei Y, Szekeres C et al (2009) Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119:213–224
Koinuma D, Shinozaki M, Komuro A et al (2003) Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J 22:6458–6470
Koinuma D, Tsutsumi S, Kamimura N et al (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol Cell Biol 29:172–186
Koinuma D, Shinozaki M, Nagano Y et al (2011) RB1CC1 protein positively regulates transforming growth factor-β signaling through the modulation of Arkadia E3 ubiquitin ligase activity. J Biol Chem 286:32502–32512
Komuro A, Imamura T, Saitoh M et al (2004) Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene 23:6914–6923
Kowanetz M, Valcourt U, Bergström R et al (2004) Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol Cell Biol 24:4241–4254
Kowanetz M, Lönn P, Vanlandewijck M et al (2008) TGFβ induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol 182:655–662
Kretzschmar M, Doody J, Timokhina I, Massagué J (1999) A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev 13:804–816
Kuratomi G, Komuro A, Goto K et al (2005) NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4–2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J 386:461–470
Kurisaki A, Kose S, Yoneda Y et al (2001) Transforming growth factor-β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner. Mol Biol Cell 12:1079–1091
Kurisaki A, Kurisaki K, Kowanetz M et al (2006) The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. Mol Cell Biol 26:1318–1332
Kwon S, Christian JL (2011) Sortilin associates with transforming growth factor-β family proteins to enhance lysosome-mediated degradation. J Biol Chem 286:21876–21885
Lallemand F, Seo SR, Ferrand N et al (2005) AIP4 restricts transforming growth factor-β signaling through a ubiquitination-independent mechanism. J Biol Chem 280:27645–27653
Lamouille S, Derynck R (2007) Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178:437–451
Lamouille S, Connolly E, Smyth JW et al (2012) TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125:1259–1273
Le Scolan E, Zhu Q, Wang L et al (2008) Transforming growth factor-β suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res 68:3277–3285
Lee PS, Chang C, Liu D, Derynck R (2003) Sumoylation of Smad4, the common Smad mediator of transforming growth factor-β family signaling. J Biol Chem 278:27853–27863
Lee B-H, Chen W, Stippec S, Cobb MH (2007a) Biological cross-talk between WNK1 and the transforming growth factor β-Smad signaling pathway. J Biol Chem 282:17985–17996
Lee MK, Pardoux C, Hall MC et al (2007b) TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26:3957–3967
Lee J, Moon HJ, Lee JM, Joo CK (2010) Smad3 regulates Rho signaling via NET1 in the transforming growth factor-β-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells. J Biol Chem 285:26618–26627
Levy L, Howell M, Das D et al (2007) Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27:6068–6083
Liang M, Liang YY, Wrighton K et al (2004) Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol 24:7524–7537
Lin X, Liang M, Feng XH (2000) Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J Biol Chem 275:36818–36822
Lin X, Liang M, Liang YY et al (2003) SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem 278:31043–31048
Lin X, Duan X, Liang YY et al (2006) PPM1A functions as a Smad phosphatase to terminate TGFβ signaling. Cell 125:915–928
Liu Z, Lin X, Cai Z et al (2011) Global identification of SMAD2 target genes reveals a role for multiple co-regulatory factors in zebrafish early gastrulas. J Biol Chem 286:28520–28532
Liu YN, Abou-Kheir W, Yin JJ et al (2012) Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol 32:941–953
Long X, Miano JM (2011) Transforming growth factor-β1 (TGF-β1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells. J Biol Chem 286:30119–30129
Lönn P, van der Heide L, Dahl M et al (2010) PARP-1 attenuates Smad-mediated transcription. Mol Cell 40:521–532
Lönn P, Vanlandewijck M, Raja E et al (2012) Transcriptional induction of salt-inducible kinase 1 by transforming growth factor β leads to negative regulation of type I receptor signaling in cooperation with the Smurf2 ubiquitin ligase. J Biol Chem 287:12867–12878
López-Casillas F, Payne HM, Andres JL, Massagué J (1994) Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 124:557–568
Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J Biol Chem 285:41328–41336
Luo K, Stroschein SL, Wang W et al (1999) The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev 13:2196–2206
Massagué J (2004) G1 cell-cycle control and cancer. Nature 432:298–306
Matsuura I, Denissova NG, Wang G et al (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226–231
Matsuura I, Chiang KN, Lai CY et al (2010) Pin1 promotes transforming growth factor-β-induced migration and invasion. J Biol Chem 285:1754–1764
Millet C, Yamashita M, Heller M et al (2009) A negative feedback control of transforming growth factor-β signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem 284:19808–19816
Miyake T, Alli NS, McDermott JC (2010) Nuclear function of Smad7 promotes myogenesis. Mol Cell Biol 30:722–735
Mizutani A, Koinuma D, Tsutsumi S et al (2011) Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4α in HepG2 cells. J Biol Chem 286:29848–29860
Morén A, Hellman U, Inada Y et al (2003) Differential ubiquitination defines the functional status of the tumor suppressor Smad4. J Biol Chem 278:33571–33582
Morén A, Raja E, Heldin C-H, Moustakas A (2011) Negative regulation of TGFβ signaling by the kinase LKB1 and the scaffolding protein LIP1. J Biol Chem 286:341–353
Mori S, Matsuzaki K, Yoshida K et al (2004) TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 23:7416–7429
Moustakas A, Heldin C-H (2009) The regulation of TGFβ signal transduction. Development 136:3699–3714
Moustakas A, Heldin C-H (2012) Induction of epithelial-mesenchymal transition by transforming growth factor β. Semin Cancer Biol 22:446–454
Mu Y, Sundar R, Thakur N et al (2011) TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2:330
Mulder KM (2000) Role of Ras and Mapks in TGFβ signaling. Cytokine Growth Factor Rev 11:23–35
Mullen AC, Orlando DA, Newman JJ et al (2011) Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell 147:565–576
Nagano Y, Mavrakis KJ, Lee KL et al (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling. J Biol Chem 282:20492–20501
Nakano A, Koinuma D, Miyazawa K et al (2009) Pin1 down-regulates transforming growth factor-β (TGF-β) signaling by inducing degradation of Smad proteins. J Biol Chem 284:6109–6115
Nakao A, Afrakhte M, Morén A et al (1997) Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631–635
Nicolas FJ, De Bosscher K, Schmierer B, Hill CS (2004) Analysis of Smad nucleocytoplasmic shuttling in living cells. J Cell Sci 117:4113–4125
Niimi H, Pardali K, Vanlandewijck M et al (2007) Notch signaling is necessary for epithelial growth arrest by TGF-β. J Cell Biol 176:695–707
Nishimura SL (2009) Integrin-mediated transforming growth factor-β activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 175:1362–1370
Ohashi S, Natsuizaka M, Naganuma S et al (2011) A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 71:6836–6847
Ohshima T, Shimotohno K (2003) Transforming growth factor-β-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem 278:50833–50842
Ozdamar B, Bose R, Barrios-Rodiles M et al (2005) Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 307:1603–1609
Papadimitriou E, Vasilaki E, Vorvis C et al (2012) Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition. Oncogene 31:2862–2875
Pardali E, Goumans MJ, ten Dijke P (2010) Signaling by members of the TGF-β family in vascular morphogenesis and disease. Trends Cell Biol 20:556–567
Park SS, Eom YW, Kim EH et al (2004) Involvement of c-Src kinase in the regulation of TGF-β1-induced apoptosis. Oncogene 23:6272–6281
Penheiter SG, Mitchell H, Garamszegi N et al (2002) Internalization-dependent and -independent requirements for transforming growth factor β receptor signaling via the Smad pathway. Mol Cell Biol 22:4750–4759
Perlman R, Schiemann WP, Brooks MW et al (2001) TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708–714
Pierreux CE, Nicolas FJ, Hill CS (2000) Transforming growth factor β-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 20:9041–9054
Pulaski L, Landström M, Heldin C-H, Souchelnytskyi S (2001) Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J Biol Chem 276:14344–14349
Qiu T, Wu X, Zhang F et al (2010) TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat Cell Biol 12:224–234
Roelen BA, Cohen OS, Raychowdhury MK et al (2003) Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-β-induced nuclear accumulation. Am J Physiol Cell Physiol 285:C823–C830
Sadej R, Romanska H, Kavanagh D et al (2010) Tetraspanin CD151 regulates transforming growth factor β signaling: implication in tumor metastasis. Cancer Res 70:6059–6070
Sapkota G, Knockaert M, Alarcon C et al (2006) Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem 281:40412–40419
Schmierer B, Hill CS (2005) Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor β-dependent nuclear accumulation of Smads. Mol Cell Biol 25:9845–9858
Schmierer B, Hill CS (2007) TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970–982
Schmierer B, Tournier AL, Bates PA, Hill CS (2008) Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci USA 105:6608–6613
Seo SR, Lallemand F, Ferrand N et al (2004) The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J 23:3780–3792
Seong H-A, Jung H, Ha H (2010) Murine protein serine/threonine kinase 38 stimulates TGF-β signaling in a kinase-dependent manner via direct phosphorylation of Smad proteins. J Biol Chem 285:30959–30970
Sflomos G, Kostaras E, Panopoulou E et al (2011) ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN. J Cell Sci 124:3209–3222
Sharma V, Antonacopoulou AG, Tanaka S et al (2011) Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer. Cancer Res 71:6438–6449
Shen X, Li J, Hu PP et al (2001) The activity of guanine exchange factor NET1 is essential for transforming growth factor-β-mediated stress fiber formation. J Biol Chem 276:15362–15368
Shi Y, Wang YF, Jayaraman L et al (1998) Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94:585–594
Shi W, Sun C, He B et al (2004) GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor. J Cell Biol 164:291–300
Shi M, Zhu J, Wang R et al (2011) Latent TGF-β structure and activation. Nature 474:343–349
Shirakihara T, Horiguchi K, Miyazawa K et al (2011) TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J 30:783–795
Simonsson M, Heldin C-H, Ericsson J, Grönroos E (2005) The balance between acetylation and deacetylation controls Smad7 stability. J Biol Chem 280:21797–21803
Simonsson M, Kanduri M, Grönroos E et al (2006) The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. J Biol Chem 281:39870–39880
Soond SM, Chantry A (2011) Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Oncogene 30:2451–2462
Sorrentino A, Thakur N, Grimsby S et al (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199–1207
Stroschein SL, Wang W, Zhou SL et al (1999) Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771–774
Sun H, Li D, Chen S et al (2010) Zili inhibits transforming growth factor-β signaling by interacting with Smad4. J Biol Chem 285:4243–4250
Tajima Y, Goto K, Yoshida M et al (2003) Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-β signaling by Smad7. J Biol Chem 278:10716–10721
Tam BY, Finnson KW, Philip A (2003) Glycosylphosphatidylinositol-anchored proteins regulate transforming growth factor-β signaling in human keratinocytes. J Biol Chem 278:49610–49617
Tanaka Y, Kobayashi H, Suzuki M et al (2004) Transforming growth factor-β1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 279:8567–8576
Tang LY, Yamashita M, Coussens NP et al (2011) Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3. EMBO J 30:4777–4789
Thillainadesan G, Chitilian JM, Isovic M et al (2012) TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 46:636–649
Tsukazaki T, Chiang TA, Davison AF et al (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95:779–791
Tu AW, Luo K (2007) Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor β response. J Biol Chem 282:21187–21196
Vardouli L, Moustakas A, Stournaras C (2005) LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-β. J Biol Chem 280:11448–11457
Varelas X, Sakuma R, Samavarchi-Tehrani P et al (2008) TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10:837–848
Varelas X, Samavarchi-Tehrani P, Narimatsu M et al (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev Cell 19:831–844
Vincent T, Neve EPA, Johnson JR et al (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial-mesenchymal transition. Nat Cell Biol 11:943–950
Wakabayashi Y, Tamiya T, Takada I et al (2011) Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway. J Biol Chem 286:35456–35465
Wan M, Cao X, Wu Y et al (2002) Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep 3:171–176
Wan M, Tang Y, Tytler EM et al (2004) Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1. J Biol Chem 279:14484–14487
Warzecha CC, Sato TK, Nabet B et al (2009) ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33:591–601
Watanabe M, Masuyama N, Fukuda M, Nishida E (2000) Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep 1:176–182
Watanabe Y, Itoh S, Goto T et al (2010) TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol Cell 37:123–134
Wicks SJ, Lui S, Abdel-Wahab N et al (2000) Inactivation of smad-transforming growth factor β signaling by Ca(2+)-calmodulin-dependent protein kinase II. Mol Cell Biol 20:8103–8111
Wicks SJ, Haros K, Maillard M et al (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene 24:8080–8084
Wotton D, Lo RS, Lee S, Massagué J (1999a) A Smad transcriptional corepressor. Cell 97:29–39
Wotton D, Lo RS, Swaby LA, Massague J (1999b) Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 274:37105–37110
Wotton D, Knoepfler PS, Laherty CD et al (2001) The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ 12:457–463
Wrana JL, Attisano L, Wieser R et al (1994) Mechanism of activation of the TGF-β receptor. Nature 370:341–347
Wrighton KH, Willis D, Long J et al (2006) Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-β signaling. J Biol Chem 281:38365–38375
Wrighton KH, Lin X, Feng XH (2008) Critical regulation of TGFβ signaling by Hsp90. Proc Natl Acad Sci USA 105:9244–9249
Wu MY, Hill CS (2009) TGF-β superfamily signaling in embryonic development and homeostasis. Dev Cell 16:329–343
Wu JW, Krawitz AR, Chai J et al (2002) Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-β signaling. Cell 111:357–367
Xi Q, He W, Zhang XH et al (2008) Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor β transcriptional program. J Biol Chem 283:1146–1155
Xi Q, Wang Z, Zaromytidou AI et al (2011) A poised chromatin platform for TGF-β access to master regulators. Cell 147:1511–1524
Xiao Z, Liu X, Henis YI, Lodish HF (2000a) A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc Natl Acad Sci USA 97:7853–7858
Xiao Z, Liu X, Lodish HF (2000b) Importin β mediates nuclear translocation of Smad 3. J Biol Chem 275:23425–23428
Xiao Z, Latek R, Lodish HF (2003) An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Oncogene 22:1057–1069
Xin H, Xu X, Li L et al (2005) CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem 280:20842–20850
Xu L, Chen YG, Massagué J (2000) The nuclear import function of Smad2 is masked by SARA and unmasked by TGFβ-dependent phosphorylation. Nat Cell Biol 2:559–562
Xu L, Kang Y, Col S, Massagué J (2002) Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFβ signaling complexes in the cytoplasm and nucleus. Mol Cell 10:271–282
Xu L, Alarcon C, Col S, Massague J (2003) Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J Biol Chem 278:42569–42577
Xu L, Yao X, Chen X et al (2007) Msk is required for nuclear import of TGFβ/BMP-activated Smads. J Cell Biol 178:981–994
Xue G, Restuccia DF, Lan Q et al (2012) Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGFβ signaling axes. Cancer Discov 2:248–259
Yagi K, Goto D, Hamamoto T et al (1999) Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J Biol Chem 274:703–709
Yakymovych I, ten Dijke P, Heldin C-H, Souchelnytskyi S (2001) Regulation of Smad signaling by protein kinase C. FASEB J 15:553–555
Yamashita M, Fatyol K, Jin C et al (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell 31:918–924
Yan X, Zhang J, Pan L et al (2011) TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. Mol Cell Biol 31:3700–3709
Yao X, Chen X, Cottonham C, Xu L (2008) Preferential utilization of Imp7/8 in nuclear import of Smads. J Biol Chem 283:22867–22874
Yi JY, Shin I, Arteaga CL (2005) Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280:10870–10876
Yilmaz M, Maass D, Tiwari N et al (2011) Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis. EMBO J 30:4489–4499
Yu J, Pan L, Qin X et al (2010) MTMR4 attenuates transforming growth factor β (TGFβ) signaling by dephosphorylating R-Smads in endosomes. J Biol Chem 285:8454–8462
Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP (2004) Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23:1155–1165
Zawel L, Dai JL, Buckhaults P et al (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611–617
Zhang Y, Chang C, Gehling DJ et al (2001) Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 98:974–979
Zhang L, Fujita T, Wu G et al (2011) Phosphorylation of the anaphase-promoting complex/Cdc27 is involved in TGF-β signaling. J Biol Chem 286:10041–10050
Zhang L, Huang H, Zhou F et al (2012a) RNF12 controls embryonic stem cell fate and morphogenesis in zebrafish embryos by targeting Smad7 for degradation. Mol Cell 46:650–661
Zhang L, Zhou F, Drabsch Y et al (2012b) USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat Cell Biol 14:717–726
Zhao Y, Thornton AM, Kinney MC et al (2011) The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells. J Biol Chem 286:40520–40530
Zhou Q, Fan J, Ding X et al (2010) TGF-β-induced MiR-491-5p expression promotes Par-3 degradation in rat proximal tubular epithelial cells. J Biol Chem 285:40019–40027
Zhou B, Liu Y, Kahn M et al (2012) Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem 287:7026–7038
Zhu H, Kavsak P, Abdollah S et al (1999) A Smad ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687–693
Zhu S, Wang W, Clarke DC, Liu X (2007) Activation of Mps1 promotes transforming growth factor-β-independent Smad signaling. J Biol Chem 282:18327–18338
Acknowledgment
Ingegärd Schiller is gratefully acknowledged for valuable help in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer
About this chapter
Cite this chapter
Heldin, CH. (2013). Transforming Growth Factor-β Signaling. In: Moustakas, A., Miyazawa, K. (eds) TGF-β in Human Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54409-8_1
Download citation
DOI: https://doi.org/10.1007/978-4-431-54409-8_1
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54408-1
Online ISBN: 978-4-431-54409-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)